Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by MasterAlgae on Oct 08, 2021 3:14pm

AME

What we don't know is how many subjects in the AME study had elevated liver enzyme tests beside the two which had the 500% above normal and triggered the Health Canada suspension.

It would take some risk-taking on Health Canada's part to give the go-ahead for its lead compound ATB-346 - if there were elevated numbers all-over-the-place with other patients. Does anyone actually know what the other numbers were? Were they all between 300 and 400% above normal or 10 to 20% above normal? Big difference.
If we don't know the other numbers - it is a very important unknown.

If you were a Health Canada employee you would be strictly walking the safety-line even if it meant that ATB-386 gets "re-formulated". You can bet that Health Canada will be in full CMA mode, now that they have been pulled into this. Of course they were always indirectly involved hence the automatic suspension.

Antibe could say it was going to focus on its other compounds in the pipeline and that they were still in discussions with potential a partners going forward - that does not mean jack. I'd say that too. That's expected. If that is what the release says then I think this will be .50 and lower instantly. The company can coast comfortably and pudder with rats "adding-value" by exploring other compounds for this-and-that with the cash they have - they have zero pressure. They can slow down the cash burn and take home cheques for years - they got the money...they have control of the company, feet up.

Obviously - I could be wrong - Monday they could announce the suspension lifted and resumption, and they have new patent protection applications, potential new drugs to look at. etc... etc...and they are in discussions with potential partners....
Comment by StockingUp21 on Oct 08, 2021 4:26pm
Muggy is typing long response to say he will be buying shares in any situation. but if news will be bad he already sold and waiting to buy again  
Comment by TheMadMonk on Oct 08, 2021 5:13pm
I don't know about Mugsy, but if this thing drops to 50 cents, I will buy everything I can get my hands on.  The funny thing is that no one here expects it to drop below a dollar because if you did expect it to drop, you would sell now.   
Comment by Inthepez on Oct 08, 2021 5:26pm
Same here. But I’ll be buying anything under $1. all these fud fairies wouldn’t be commenting on this stock if they didn’t have a stake in it. Bunch of b!tches that love to complain and spread false info.  Im looking at you: ratbar, yukonjizza, the xdresser, and of course dusty. Although dusty has been MIA lately lmao! 
Comment by Rarbar99 on Oct 09, 2021 10:19am
Back in June 17, you made a comment telling people that you think $4 is a good entry price. Fast forward a few months later, you're now waiting to buy under $1 to average down. Hilarious 
Comment by MrMugsy on Oct 09, 2021 11:01am
I have never seen a stock that wen't to half cash value but then again ... I've never paid this much attention to a drug development company before. I couldn't imagine it getting to 50 cents or even 75 cents but I certainly would evaluate the situation at that time - if the price dropped. I have been buying back on the daily now - so if it drops on no news - guess logic would dictate ...more  
Comment by StockingUp21 on Oct 09, 2021 3:06pm
huh when did you sell muggy?   
Comment by MrMugsy on Oct 09, 2021 9:06pm
hahaha - not sure why I used the word "back" - oh well
Comment by MrMugsy on Oct 09, 2021 10:33am
Master algae ... I thought the 100 mg dose had 3 elevated engine issues and one might be unrelated.  I also think there were no issues at 75 mg.  Also - I don’t see any need to abandon OTENA. IMO
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities